You have access
Cessation of Tyrosine Kinase Inhibitors in Patients with Chronic-phase Chronic Myelogenous Leukemia Following Durable Complete Molecular Response: A Single Center Facing the Dilemma
THEODOROS ILIAKIS, VASILIKI PAPADOPOULOU, PANAGIOTIS T. DIAMANTOPOULOS, PANAYIOTIS PANAYIOTIDIS, KONSTANTINOS ZERVAKIS, NEFELI GIANNAKOPOULOU, GERASSIMOS TILIMIDOS, MARIA ANGELOPOULOU, MARINA P. SIAKANTARIS, GERASSIMOS PANGALIS, MARINA MANTZOURANI, ELENI VARIAMI and NORA ATHINA VINIOU
Anticancer Research August 2013, 33 (8) 3509-3514;